Don’t forget to tune into our quarterly conference call and webcast starting at 4:30 p.m. ET today. <<<Click the link to access the webcast https://bit.ly/4kG2p0c>>> #CAPR
Capricor Therapeutics, Inc.
Biotechnology Research
San Diego, CA - California 11,333 followers
Capricor (NASDAQ: CAPR) is a biotechnology company developing cell and exosome-based therapeutics for serious diseases.
About us
Capricor Therapeutics is a publicly traded (NASDAQ: CAPR) biotechnology company with a mission to develop groundbreaking therapies that make a meaningful impact on patients’ lives. Capricor is focused on the development of biologics, primarily cell and exosome-based technologies to treat or prevent a broad range of diseases. Our lead product is a cell therapy designed to treat Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy, which results in muscle degeneration and premature death. Capricor’s innovative exosome technology is focusing on engineering exosomes to treat or prevent diseases with high unmet medical needs. Our translational approach to product development is based on the strong research foundation provided by our academic partnerships with leading scientists at top-tier research institutions.
- Website
-
http://www.capricor.com
External link for Capricor Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Diego, CA - California
- Type
- Public Company
- Founded
- 2005
- Specialties
- Biotechnology, Duchenne muscular dystrophy, RNA Therapeutics, Extracellular Vesicles , Exosomes, Cell Therapy , Rare Diseases, and Infectious Diseases
Locations
-
Primary
Get directions
10865 Road To The Cure
Ste 150
San Diego, CA - California 92121, US
Employees at Capricor Therapeutics, Inc.
Updates
-
Capricor just announced our fourth quarter and full year 2024 financial results and corporate update. <<<Click to read the press release https://bit.ly/3E0uyyA>>> #CAPR
-
-
Capricor is pleased to share the data from our late-breaking poster which was showcased over the weekend at the 2025 MDA Conference in Dallas. <<<Click the link to read the press release https://bit.ly/4iinMmP>>> #MDA2025 #CAPR #Neuromuscular #MuscularDystrophy #DMD #deramiocel
-
-
The 2025 Muscular Dystrophy Association (MDA) Conference starts this weekend in Dallas, Texas! MDA brings together clinicians, researchers, and industry leaders to share the latest breakthroughs in DMD and other neuromuscular diseases. Capricor will be featured in the late-breaking poster session (# LB438) and will be hosting a booth (#813) to showcase the latest information on our deramiocel program. #MDA2025 #CAPR #Neuromuscular #MuscularDystrophy #DMD #deramiocel
-
-
Don't miss Capricor's presentation today, March 12 at 1:00 p.m. ET. We will be present at the 2025 Leerink Global Healthcare Conference in Miami, FL. To register for the webcast, click here: https://lnkd.in/gkHprmDJ #CAPR #deramiocel #DMD
-
-
On March 19, 2025, Capricor will release our fourth quarter and full year 2024 financial results and host our conference call at 4:30 p.m. ET #CAPR <<<Click to register for the webcast https://bit.ly/4kG2p0c>>>
-
-
Capricor Therapeutics, Inc. reposted this
News just in - the FDA has accepted the Biologics License Application (BLA) for deramiocel, an investigational cell therapy for Duchenne cardiomyopathy! This is a significant step forward for the Duchenne community, and we are excited to partner with Capricor Therapeutics, Inc. to bring new hope and potential treatments to patients and their families. Read more about it here: https://ow.ly/rKZO50Vcx5G #Duchenne #DMD #RareDiseases
-
-
Capricor is delighted to be presenting at the 2025 Leerink Global Healthcare Conference in Miami, FL. Our presentation will be on Wednesday, March 12 at 1:00 p.m. ET To register for the webcast, click here: https://lnkd.in/gkHprmDJ #CAPR #deramiocel #DMD
-
-
Reminder we are hosting a webinar with PPMD today at 1:00 p.m. ET to discuss the latest updates on our deramiocel program. #CAPR #PPMD #DMD #deramiocel <<<Click to register https://lnkd.in/g4bky9m6>>>
-
-
Reminder we are hosting a webinar with PPMD today at 1:00 p.m. ET to discuss the latest updates on our deramiocel program. #CAPR #PPMD #DMD #deramiocel <<<Click to register https://lnkd.in/g4bky9m6>>>
-